Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Ltd has announced the quotation of 365,338 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of October 2, 2025. This move is part of the company’s strategy to enhance its financial flexibility and support its growth initiatives, potentially impacting its market position and providing value to its stakeholders.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on innovative imaging solutions. The company is known for its advanced respiratory imaging products, which aim to improve patient outcomes and streamline healthcare processes.
Average Trading Volume: 6,845,466
Technical Sentiment Signal: Buy
Current Market Cap: A$1.14B
For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.